拜玛林制药:因两项研究者发起试验中发生多起股骨头骨骺滑脱事件而决定终止研究

美股速递
Mar 16

拜玛林制药宣布,由于两项正在进行的研究者发起试验中出现了数例股骨头骨骺滑脱事件,公司已决定终止这些研究项目。该决定基于对患者安全的审慎评估,旨在优先保障临床试验参与者的福祉。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10